# XHANCE
> **NDA209022** · New Drug Application · Sponsor: PARATEK PHARMS · Approved 2017-09-18
## Drug
- **FDA Application Number:** NDA209022
- **Application type:** New Drug Application
- **Brand name:** XHANCE
- **Generic name:** FLUTICASONE PROPIONATE
- **Active ingredients:** FLUTICASONE PROPIONATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** PARATEK PHARMS
- **Manufacturer:** OptiNose US, Inc.
- **First approval:** 2017-09-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209022)
---
*AI Analytics · CC0 1.0*